AREV NanoTec Brands Inc
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES… Read more
AREV NanoTec Brands Inc (AREVF) - Net Assets
Latest net assets as of September 2023: $-1.16 Million USD
Based on the latest financial reports, AREV NanoTec Brands Inc (AREVF) has net assets worth $-1.16 Million USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($213.29K) and total liabilities ($1.38 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.16 Million |
| % of Total Assets | -545.3% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 213.2 |
AREV NanoTec Brands Inc - Net Assets Trend (2008–2022)
This chart illustrates how AREV NanoTec Brands Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AREV NanoTec Brands Inc (2008–2022)
The table below shows the annual net assets of AREV NanoTec Brands Inc from 2008 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-952.61K | -918.75% |
| 2021-12-31 | $-93.51K | +85.42% |
| 2020-12-31 | $-641.23K | -21.96% |
| 2019-12-31 | $-525.79K | -132.19% |
| 2018-12-31 | $-226.45K | -123.61% |
| 2017-12-31 | $959.26K | +422.03% |
| 2016-12-31 | $183.75K | +211.82% |
| 2015-12-31 | $-164.34K | -104.96% |
| 2014-12-31 | $-80.18K | -1517.20% |
| 2013-12-31 | $-4.96K | -117.06% |
| 2012-12-31 | $29.06K | -62.75% |
| 2011-12-31 | $78.01K | +895.27% |
| 2010-12-31 | $-9.81K | -246.36% |
| 2009-12-31 | $6.70K | -97.12% |
| 2008-12-31 | $232.65K | -- |
Equity Component Analysis
This analysis shows how different components contribute to AREV NanoTec Brands Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1663660700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.67 Million | % |
| Other Comprehensive Income | $101.12K | % |
| Other Components | $2.83 Million | % |
| Total Equity | $-952.61K | 100.00% |
AREV NanoTec Brands Inc Competitors by Market Cap
The table below lists competitors of AREV NanoTec Brands Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Korea Line Corp.
KQ:005880
|
$15.88K |
|
Ionic Brands Corp
PINK:IONKF
|
$15.89K |
|
SH INDUSTRIAL
MU:SGI
|
$15.90K |
|
NPC Co. Ltd. Pfd. Series 1
KQ:004255
|
$15.90K |
|
Sumer Varlik Yonetim A.S.
IS:SMRVA
|
$15.88K |
|
Btg Pactual Teva Tesouro Ipca Ultra Longo Ce Fundo De Indice - Responsabilidade Limitada
SA:PACB11
|
$15.87K |
|
Vantex Resources Ltd
PINK:VANTF
|
$15.87K |
|
Grand Peak Capital Corp
PINK:GPKUF
|
$15.86K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AREV NanoTec Brands Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -93,508 to -952,609, a change of -859,101.
- Net loss of 1,444,106 reduced equity.
- Other comprehensive income decreased equity by 2,755,463.
- Other factors increased equity by 3,340,468.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.44 Million | -151.59% |
| Other Comprehensive Income | $-2.76 Million | -289.25% |
| Other Changes | $3.34 Million | +350.67% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares AREV NanoTec Brands Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $39.42 | $0.01 | x |
| 2009-12-31 | $1.14 | $0.01 | x |
| 2010-12-31 | $-1.66 | $0.01 | x |
| 2011-12-31 | $12.33 | $0.01 | x |
| 2012-12-31 | $4.49 | $0.01 | x |
| 2013-12-31 | $-0.91 | $0.01 | x |
| 2014-12-31 | $-13.93 | $0.01 | x |
| 2015-12-31 | $-32.12 | $0.01 | x |
| 2016-12-31 | $17.82 | $0.01 | x |
| 2017-12-31 | $0.40 | $0.01 | x |
| 2018-12-31 | $-0.04 | $0.01 | x |
| 2019-12-31 | $-0.06 | $0.01 | x |
| 2020-12-31 | $-0.04 | $0.01 | x |
| 2021-12-31 | $0.00 | $0.01 | x |
| 2022-12-31 | $-0.03 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AREV NanoTec Brands Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2940.37%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-253.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -96.32% | -74.69% | 0.92x | 1.40x | $-247.35K |
| 2009 | -3371.38% | 0.00% | 0.00x | 15.60x | $-226.62K |
| 2010 | 0.00% | -41.80% | 0.50x | 0.00x | $-15.53K |
| 2011 | 79.11% | 59.60% | 0.74x | 1.80x | $53.91K |
| 2012 | -168.47% | 0.00% | 0.00x | 2.87x | $-51.86K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-33.52K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-67.20K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-67.72K |
| 2016 | -136.95% | 0.00% | 0.00x | 4.32x | $-270.03K |
| 2017 | -106.33% | 0.00% | 0.00x | 1.73x | $-1.12 Million |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-8.40 Million |
| 2019 | 0.00% | -1639.99% | 0.22x | 0.00x | $-3.14 Million |
| 2020 | 0.00% | -550.37% | 0.15x | 0.00x | $-984.75K |
| 2021 | 0.00% | -388.36% | 0.41x | 0.00x | $-980.96K |
| 2022 | 0.00% | -2940.37% | 0.19x | 0.00x | $-1.35 Million |
Industry Comparison
This section compares AREV NanoTec Brands Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AREV NanoTec Brands Inc (AREVF) | $-1.16 Million | -96.32% | N/A | $15.88K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |